Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype--Locked(TM) CAR--Tregs in LIBERATE Phase 1/2 Liver Transplant Study

Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aims to harness, direct and optimize their immune suppressive properties to address serious ...

Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype‑Locked™ CAR‑Tregs in LIBERATE Phase 1/2 Liver Transplant Study

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...

From War Correspondent to Global Communications Leader: Adriana Aristizábal to Address UN Commission on Status of Women

Latina Communications Executive and Founder of iVoice Communications joins the global dialogue on women’s leadership ...
CEOWORLD magazine

Inside DJI’s $3.2 Billion Sky: Frank Wang, Drones and Asia’s New Youngest Tech Billionaire

Frank Wang didn’t set out to become Asia’s youngest tech billionaire. He just wanted his homemade drone to stop falling out ...
Opinion
iAfricaOpinion

Africa’s Next Global Export Won’t Be Minerals. It Will Be AI

I’ve been fortunate to invest in several AI funding rounds—from pre-seed to Series B to F—and to see up close how billions have flowed into ...